251 related articles for article (PubMed ID: 25009280)
21. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis.
Verde F; Steinacker P; Weishaupt JH; Kassubek J; Oeckl P; Halbgebauer S; Tumani H; von Arnim CAF; Dorst J; Feneberg E; Mayer B; Müller HP; Gorges M; Rosenbohm A; Volk AE; Silani V; Ludolph AC; Otto M
J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):157-164. PubMed ID: 30309882
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal biomarkers in amyotrophic lateral sclerosis.
Huang F; Zhu Y; Hsiao-Nakamoto J; Tang X; Dugas JC; Moscovitch-Lopatin M; Glass JD; Brown RH; Ladha SS; Lacomis D; Harris JM; Scearce-Levie K; Ho C; Bowser R; Berry JD
Ann Clin Transl Neurol; 2020 Jul; 7(7):1103-1116. PubMed ID: 32515902
[TBL] [Abstract][Full Text] [Related]
23. The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA.
Koel-Simmelink MJ; Vennegoor A; Killestein J; Blankenstein MA; Norgren N; Korth C; Teunissen CE
J Immunol Methods; 2014 Jan; 402(1-2):43-9. PubMed ID: 24275679
[TBL] [Abstract][Full Text] [Related]
24. Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes.
Vu L; An J; Kovalik T; Gendron T; Petrucelli L; Bowser R
J Neurol Neurosurg Psychiatry; 2020 Apr; 91(4):350-358. PubMed ID: 31937582
[TBL] [Abstract][Full Text] [Related]
25. Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials.
Witzel S; Frauhammer F; Steinacker P; Devos D; Pradat PF; Meininger V; Halbgebauer S; Oeckl P; Schuster J; Anders S; Dorst J; Otto M; Ludolph AC
Transl Neurodegener; 2021 Aug; 10(1):31. PubMed ID: 34433481
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.
Gaiani A; Martinelli I; Bello L; Querin G; Puthenparampil M; Ruggero S; Toffanin E; Cagnin A; Briani C; Pegoraro E; Sorarù G
JAMA Neurol; 2017 May; 74(5):525-532. PubMed ID: 28264096
[TBL] [Abstract][Full Text] [Related]
27. Performance of serum neurofilament light chain in a wide spectrum of clinical courses of amyotrophic lateral sclerosis-a cross-sectional multicenter study.
Meyer T; Salkic E; Grehl T; Weyen U; Kettemann D; Weydt P; Günther R; Lingor P; Koch JC; Petri S; Hermann A; Prudlo J; Großkreutz J; Baum P; Boentert M; Metelmann M; Norden J; Cordts I; Weishaupt JH; Dorst J; Ludolph A; Koc Y; Walter B; Münch C; Spittel S; Dreger M; Maier A; Körtvélyessy P
Eur J Neurol; 2023 Jun; 30(6):1600-1610. PubMed ID: 36899448
[TBL] [Abstract][Full Text] [Related]
28. Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
Xu Z; Henderson RD; David M; McCombe PA
PLoS One; 2016; 11(10):e0164625. PubMed ID: 27732645
[TBL] [Abstract][Full Text] [Related]
29. Axonal damage markers in cerebrospinal fluid are increased in ALS.
Brettschneider J; Petzold A; Süssmuth SD; Ludolph AC; Tumani H
Neurology; 2006 Mar; 66(6):852-6. PubMed ID: 16567701
[TBL] [Abstract][Full Text] [Related]
30. SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study.
Martinelli I; Zucchi E; Simonini C; Gianferrari G; Bedin R; Biral C; Ghezzi A; Fini N; Carra S; Mandrioli J
Eur J Neurol; 2024 Jan; 31(1):e16054. PubMed ID: 37679868
[TBL] [Abstract][Full Text] [Related]
31. Serum Neurofilaments in Motor Neuron Disease and Their Utility in Differentiating ALS, PMA and PLS.
McCluskey G; Morrison KE; Donaghy C; McConville J; McCarron MO; McVerry F; Duddy W; Duguez S
Life (Basel); 2023 May; 13(6):. PubMed ID: 37374084
[TBL] [Abstract][Full Text] [Related]
32. A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament "hook" effect.
Lu CH; Kalmar B; Malaspina A; Greensmith L; Petzold A
J Neurosci Methods; 2011 Feb; 195(2):143-50. PubMed ID: 21134399
[TBL] [Abstract][Full Text] [Related]
33. Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis.
Feneberg E; Oeckl P; Steinacker P; Verde F; Barro C; Van Damme P; Gray E; Grosskreutz J; Jardel C; Kuhle J; Koerner S; Lamari F; Amador MDM; Mayer B; Morelli C; Muckova P; Petri S; Poesen K; Raaphorst J; Salachas F; Silani V; Stubendorff B; Turner MR; Verbeek MM; Weishaupt JH; Weydt P; Ludolph AC; Otto M
Neurology; 2018 Jan; 90(1):e22-e30. PubMed ID: 29212830
[TBL] [Abstract][Full Text] [Related]
34. Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease.
van der Burgh HK; Westeneng HJ; Meier JM; van Es MA; Veldink JH; Hendrikse J; van den Heuvel MP; van den Berg LH
Neuroimage Clin; 2019; 24():101984. PubMed ID: 31499409
[TBL] [Abstract][Full Text] [Related]
35. Phosphorylation state of the native high-molecular-weight neurofilament subunit protein from cervical spinal cord in sporadic amyotrophic lateral sclerosis.
Strong MJ; Strong WL; Jaffe H; Traggert B; Sopper MM; Pant HC
J Neurochem; 2001 Mar; 76(5):1315-25. PubMed ID: 11238716
[TBL] [Abstract][Full Text] [Related]
36. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis.
Weydt P; Oeckl P; Huss A; Müller K; Volk AE; Kuhle J; Knehr A; Andersen PM; Prudlo J; Steinacker P; Weishaupt JH; Ludolph AC; Otto M
Ann Neurol; 2016 Jan; 79(1):152-8. PubMed ID: 26528863
[TBL] [Abstract][Full Text] [Related]
37. Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker.
Boylan K; Yang C; Crook J; Overstreet K; Heckman M; Wang Y; Borchelt D; Shaw G
J Neurochem; 2009 Dec; 111(5):1182-91. PubMed ID: 19765193
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature.
Gagliardi D; Meneri M; Saccomanno D; Bresolin N; Comi GP; Corti S
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450699
[TBL] [Abstract][Full Text] [Related]
39. Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS).
Wong NK; He BP; Strong MJ
J Neuropathol Exp Neurol; 2000 Nov; 59(11):972-82. PubMed ID: 11089575
[TBL] [Abstract][Full Text] [Related]
40. Neurofilament light chain and C reactive protein explored as predictors of survival in amyotrophic lateral sclerosis.
De Schaepdryver M; Lunetta C; Tarlarini C; Mosca L; Chio A; Van Damme P; Poesen K
J Neurol Neurosurg Psychiatry; 2020 Apr; 91(4):436-437. PubMed ID: 32029541
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
